Is Prime Medicine Inc (NASDAQ: PRME) Still On The Rise?

After Hours

There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours.

Stocks Info

This NASDAQ-listed company operates within the Biotechnology industry segment, falling under the Healthcare sector. The current market capitalization of Prime Medicine Inc is $498.92M. A total of 15.71 million shares were traded on the day, compared to an average of 2.56M shares.

In the most recent transaction, Liu David R. bought 21,000 shares of PRME for 2.52 per share on Jun 30 ’25. After the transaction, the 10% Owner now owns 20,240,945 company shares. In a previous transaction on Jun 23 ’25, Liu David R. bought 21,000 shares at 2.16 per share. PRME shares that 10% Owner owns now total 20,219,945.

Among the insiders who bought shares, Liu David R. acquired of 21,000 shares on Jun 16 ’25 at a per-share price of $1.49. This resulted in the 10% Owner holding 20,198,945 shares of PRME after the transaction. In another insider transaction, Liu David R. bought 21,000 shares at $1.60 per share on Jun 11 ’25. Company shares held by the 10% Owner now total 20,177,945.

Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, PRME has a high of $6.75 and a low of $1.11.

Balance Sheet Annually/Quarterly

In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. PRME’s latest balance sheet shows that the firm has $269.62M in Cash & Short Term Investments as of fiscal 2021. There were $10.41M in debt and $57.98M in liabilities at the time. Its Book Value Per Share was $0.82, while its Total Shareholder’s Equity was $239.56M.

Analysts Opinion

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for PRME is Buy with a score of 4.27.

Related Posts

Park Telegraph
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.